Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.08
-4.6%
$0.10
$0.08
$0.47
$861K0.457,822 shs214 shs
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$4.11
-2.8%
$4.25
$2.43
$16.08
$3.61M2.03647,782 shs69,535 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.16
+4.1%
$0.13
$0.06
$6.80
$3.29M0.46590,142 shs126,547 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.28
+2.7%
$2.98
$2.10
$17.49
$3.25M-0.03383,732 shs27,503 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%-2.29%-26.21%-35.12%-80.96%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-2.84%-3.75%-40.52%-47.37%-47.43%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
+4.13%-3.81%+42.27%-13.06%-97.22%
Venus Concept Inc. stock logo
VERO
Venus Concept
+2.70%+3.64%-17.09%-33.16%-65.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.0183 of 5 stars
0.02.00.00.00.00.00.0
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.00
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.00
Hold$5.003,094.89% Upside
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.03N/AN/A$0.57 per share0.14
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$516K6.99N/AN/A$2.44 per share1.68
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.43N/AN/A($6.91) per share-0.02
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.05N/AN/A($2.43) per share-0.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%N/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$8.24MN/A0.00N/A-670.95%-201.30%-154.54%N/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08MN/A0.00N/A-563.16%N/A-174.06%5/29/2025 (Estimated)
Venus Concept Inc. stock logo
VERO
Venus Concept
-$37.25M-$76.30N/AN/A-74.62%N/A-47.46%8/11/2025 (Estimated)

Latest DYNT, TTOO, VERO, and TIVC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A-$2.52N/A-$2.52N/A$0.07 million
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
3/31/2025Q4 2024
Venus Concept Inc. stock logo
VERO
Venus Concept
-$10.0089-$11.23-$1.2211-$11.23$16.99 million$15.77 million
3/21/2025Q4 2024
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$85.00-$19.68+$65.32N/A$1.43 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
5.65
4.34
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
Venus Concept Inc. stock logo
VERO
Venus Concept
2.83
1.86
1.18

Institutional Ownership

CompanyInstitutional Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.31%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20010.62 million8.11 millionNot Optionable
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
10878,0009.44 millionNot Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionOptionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million3.70 millionNot Optionable

Recent News About These Companies

Venus Concept announces $11M debt-to-equity exchange transaction
Venus Concept reports Q4 EPS ($11.23) vs ($20.14) last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.08 0.00 (-4.59%)
As of 05/23/2025 10:30 AM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Tivic Health Systems stock logo

Tivic Health Systems NASDAQ:TIVC

$4.11 -0.12 (-2.84%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$4.19 +0.08 (+2.04%)
As of 05/23/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.16 +0.01 (+4.13%)
As of 05/23/2025 03:44 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.28 +0.06 (+2.70%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.27 -0.01 (-0.26%)
As of 05/23/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.